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journal homepage: www.elsevier.com/locate/ihjEditorialSubvalvular disease in patients undergoing balloon
mitral valvotomy: A strong base is not always good§Balloonmitral valvotomy or percutaneous transvenous mitral
commissurotomy (BMV/PTMC) is currently the treatment of
choice for severe and/or symptomatic mitral stenosis. It has
few contraindications, namely presence of a thrombus in left
atrium, signiﬁcant mitral regurgitation (MR), and severely
calciﬁed commissures in the mitral apparatus (though many
would operate now even with commissural calciﬁcation1).
BMV as a procedure has its own problems however. Long-term
event rates including death or re-intervention (either redo
BMV or open heart surgery) approach 30–50% at 5- to 10-years
follow-up. More dangerous is the threat of acute severe MR,
mostly due to anterior mitral leaﬂet tear (2–10% of all cases).
Taken together, these two form the Achilles' heel of this
procedure. Therefore, a pre-intervention assessment by
transthoracic echocardiogram is crucial for selecting the right
patient, as both the complications are rather best avoided. To
standardize this evaluation, several different scoring systems
have been proposed which are useful in predicting long-term
efﬁcacy of the procedure, acute MR, or both.
While the determinants of acute MR and long-term
procedural success do overlap, there are some important
distinctions. It would seem that excessive ﬁbrosis and/or
calciﬁcation in the mitral valvular apparatus and its compo-
nents individually predict acute failure to open the valve as
well as long-term success. This would include the leaﬂets,
commissures, and the subvalvular tissue. For the prediction of
acute MR, there is considerable disagreement however.
In this issue of the journal, Dr Balghat et al.2 present the
results of a prospectively carried out study (of patients
undergoing BMV in their tertiary care institution) of preopera-
tive echocardiographic evaluation of a new subvalvular grading
technique in comparison to traditional echocardiographic
scores and its correlation with outcome of procedural failure
(unsuccessful dilatation or severeMR requiring urgent surgery).
Besides the usual evaluation and assessment ofWilkins' score3
and MR Score,4 the authors also carried out a detailed
echocardiographic evaluation of subvalvular apparatus at-
tached to each of the papillary muscle, postero-medial, and
antero-lateral (or infero-septal and supero-lateral, respectively§ This editorial is pertaining to the article: Subvalvular apparatus
stenosis.in attitudinally correct nomenclature). This was then used to
make a simple score (SVA score) with three categories: 1 being
lack of severe involvement of both papillary muscles (and
chordate attached to them), 2 denoting severe involvement
of either papillary muscle, and 3 being severe involvement of
both. This evaluation was prospective, carried out by 4
cardiologists blinded to the procedure, and quality of data
checked by inter- and intra-observer variation assessment.
Of the 356 individuals undergoing BMV over a one-year
period, procedural success was 88%, while 8% had severe
MR requiring surgery, and in 4% the valve could not be
satisfactorily dilated. The authors noted that nearly all of these
(95%)hadanSVAscoreof 3, andalsoall patientswithascoreof 3
developed complications. This was true irrespective of leaﬂet
morphology, which varied depending on the type of complica-
tion. The overall performance of SVA score was much better
than Wilkins and Padial MR score. A good correlation
of echocardiographic ﬁndings was seen with pathology in
excisedvalvesofpatientsundergoingsurgery.Ofnote, thevalve
specimen also showed that while extensive commissural
diseasewasalwaysaccompaniedbyseveresubvalvulardisease,
the converse was not always true. The authors subsequently
hypothesize that commissural involvement is only a surrogate
for the extent of subvalvular disease, which is the only real
predictor of procedural success as well as severe post-
procedural MR. They also believe that it is the inadequacy of
SVD evaluation (for e.g., evaluating only one papillary muscle
rather than both), which is the cause of poor performance of
scores like the Wilkins Score and the Padial MR Score. They
propose the utility of their SVA score as being crucial for
identifying those patients who should not be offered BMV.
The study has been done with rigorous methodology and
has acceptable inter- and intra-observer variability, meaning
that once understood, the new SVA score is likely to be
reproducible. The question that remains to be answered is
whether the new SVA score provides any incremental value to
our pre-BMV assessment of mitral valve or even replace the
traditional scores employed. Starting with the Wilkins Score,
published in 1988,3 there have been several scores thatand adverse outcome of balloon valvotomy in rheumatic mitral
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Wilkins article, data emerged from several investigators that
the score (probably still the commonest used around the
world) had several ﬂaws. One of them was the omission of
information about the commissural fusion and calciﬁcation in
the score, which seemed to dichotomize procedural success
among thosewith 'good'Wilkins score. Thiswas subsequently
acknowledged and incorporated by the Harvard group into a
new score in 2014, which takes into account the above, along
with commissural asymmetry and subvalvular disease.5 The
other major ﬂaw with Wilkins Score is its inability to predict
severe post-procedural MR necessitating urgent or semi-
urgent mitral valve surgery. This then prompted development
of new scores for the prediction of severe MR, one of them
being the Padial score,4 designed by the same Harvard group.
However, these scores have only average performance
characteristics and are poorly reproducible across diverse
populations and studies.
It is pertinent here to look mechanistically at the causes of
failure of this otherwise excellent procedure. Stiff valvular
apparatus (due to diffuse thickening, calciﬁcation, severe
subvalvular disease, or all of them) is less likely to give way
causing either failure or under-dilatation. Less acute gain in
the valve area as well as fundamentally 'bad' valve will also
causemore restenosis in the long run. This is why theWilkins
Score is good at this kind of prediction. However, it is the
unevenness of ﬁbrosis/calciﬁcation in the valvular apparatus
that will predispose certain points (mostly the thinner part of
[(Fig._1)TD$FIG]Fig. 1 – Assessment of subvalvular apparatus in mitral stenosis.
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sometimes) for tearing and severe regurgitation. As the thicker
portions refuse to give way, the brunt of asymmetric and large
forces generated during balloon dilatation is borne by these
areas. This asymmetry can exist within the leaﬂets and
commissures, as well as between two components, for e.g.,
excessive thickening in commissures and/or subvalvular
tissue in relation to leaﬂets with the latter being less thick.
It is theAML thatmostly tears at a 'hinge' point. This iswhy the
Wilkins score will not predict procedural severe MR while the
Padial score (which takes into account leaﬂet heterogeneity) or
the proposed score by Bhalgat et al. might. Obviously, an
inappropriately large balloon (or balloon inhighpressure zone)
can cause regurgitation with diffuse thickening also.
While most of the investigators believe that leaﬂet and
commissural thickening have a strong correlation with long-
term outcomes, it is the effect of subvalvular disease that has
been a major point of contention. While some, including the
present study, claim subvalvular disease to be the major
determinant of success, others (including from India6) have
found no correlation between the two. Besides differing
population and procedural characteristics, another reason
for this discrepancy can be the way in which the subvalvular
apparatus is assessed on echocardiogram. As pointed out by
the authors, evaluation of only one of the two papillary
muscles can potentially cause both under-diagnosis and over-
diagnosis of severe SVD (Fig. 1). However, contrary to the
assertion of the authors, the original Wilkins score3 actuallyWhile both the papillary muscles and chordae have disease,
odified tilted parasternal long axis views; (C) parasternal
l 2 chamber view showing both papillary muscles. AL:
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does not provide guidance for scoring in cases, where the
involvement is asymmetric), and this has been the practice of
many others,7 including this author. Nevertheless, it is a fact
that the extent of subvalvular disease is often under-
diagnosed and this has been repeatedly demonstrated in
studies of patients undergoing emergency surgery for severe
MR following BMV. These studies invariably show under-
appreciated severe subvalvular ﬁbrosis and/or commissural
calciﬁcation along with tears in the AML.8,9
The authors are to be commended for developing a simple
tool for subvalvular disease assessment, that is easy to
standardize and perform and shows a good correlation with
surgical ﬁndings in their study. They have rightly put the focus
back on SVA, which should just not be relegated to a brief
assessment of a single papillary muscle in parasternal long
axis view. They are also correct in stating that SVD is a strong
predictor of severeMR, a fact substantiated by previous studies
as well. However, to conclude that, this assessment alone is
sufﬁcient for picking out the unsuitable BMV candidates, and
that all other valvular abnormalities are in fact surrogate for
severe SVD, might be premature. While it is likely that severe
involvement of both papillary muscles might indeed preclude
a successful procedure, absence of this parameter is unlikely to
safeguard against complications. Their ﬁnding of commissural
ﬁbrosis/calciﬁcationbeingonlyasurrogate forSVAinvolvement
may be due to small sample size and may not be reproducible.
A larger sample size and validation of their scoring in an
independent population would have been reassuring.
Hence, pending long-term data from the authors and
independent validation of this score, we would much rather
incorporate this elegantly simple andobjective SVDevaluation
in our assessment of mitral valve complex, instead of
replacing current practices entirely. It is clear however that
a 'strong base' is indeed counter-productive for the success
of BMV, and the authors are to be lauded for putting the
spotlight back on the subvalvular apparatus.
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